Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
Asset disposition
Inv. presentation
|
|
HARVARD BIOSCIENCE INC (HBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2018 |
8-K
| Asset disposition|
Docs:
|
"Merger Agreement, between Harvard Bioscience, Inc., DSI Acquisition Sub, Inc. and Data Sciences International, Inc",
"Purchase Agreement, between Harvard Bioscience, Inc., Denville Scientific, Inc. and Thomas Scientific, LLC",
"Harvard Bioscience To Acquire Data Sciences International and Sells Denville Scientific Reports 2018 Guidance -Conference Call and Webcast Scheduled for Tuesday, January 23 at 7:30 AM ET-",
"Unaudited pro forma financial information of Harvard Bioscience, Inc. as of September 30, 2017, and for the nine months ended September 30, 2017, and the years ended December 31, 2016, 2015, and 2014" |
|
| 02/25/2011 |
8-K
| Form 8-K - Current report |
|
|